Document Detail


Prenatal prediction of risk of the fetal hydantoin syndrome.
MedLine Citation:
PMID:  2336087     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The well-known teratogenicity of several anticonvulsant medications is associated with an elevated level of oxidative metabolites that are normally eliminated by the enzyme epoxide hydrolase. In this study, we attempted to determine whether infants who are at risk for congenital malformations could be identified prenatally by the measurement of epoxide hydrolase activity. Before fetuses at risk could be identified, it was necessary to measure epoxide hydrolase activity in a randomly selected sample of amniocytes from 100 pregnant women. According to a thin-layer chromatographic assay, the randomly selected sample population had an apparently trimodal distribution, suggestive of an enzyme regulated by a single gene with two allelic forms. Fetuses homozygous for the recessive allele would have low epoxide hydrolase activity and would therefore be at risk if exposed to anticonvulsant drugs during gestation. In a prospective study of 19 pregnancies monitored by amniocentesis, an adverse outcome was predicted for four fetuses on the basis of low enzyme activity (less than 30 percent of the standard). In all four cases, the mother was receiving phenytoin monotherapy, and after birth the infants had clinical findings compatible with the fetal hydantoin syndrome. The 15 fetuses with enzyme activity above 30 percent of the standard were not considered to be at risk, and all 15 neonates lacked any characteristic features of the fetal hydantoin syndrome. These preliminary results suggest that this enzymatic biomarker may prove useful in determining which infants are at increased risk for congenital malformations induced by anticonvulsant drugs.
Authors:
B A Buehler; D Delimont; M van Waes; R H Finnell
Related Documents :
4033137 - A rat model for the study of transplacental pharmacokinetics and its assessment with an...
1405727 - Open fetal spinal cord surgery in rats with low mortality achieved by prevention of oli...
2874637 - An improved procedure for the efficient injection of radioactive steroids into mouse em...
3687437 - Astrocytes in the prenatal central nervous system. from 5th to 28th week of gestation. ...
18053997 - Dietary trans fatty acid intake is associated with increased fetal loss.
3456167 - Influence of a genetic difference confined to mutation of h-2k on the incidence of preg...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The New England journal of medicine     Volume:  322     ISSN:  0028-4793     ISO Abbreviation:  N. Engl. J. Med.     Publication Date:  1990 May 
Date Detail:
Created Date:  1990-06-11     Completed Date:  1990-06-11     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  0255562     Medline TA:  N Engl J Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1567-72     Citation Subset:  AIM; IM    
Affiliation:
Hattie B. Munroe Center for Human Genetics, University of Nebraska Medical Center, Omaha.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abnormalities, Drug-Induced / diagnosis*,  etiology
Amniocentesis*
Amniotic Fluid / enzymology
Anticonvulsants / adverse effects*
Biological Markers / analysis
Epoxide Hydrolases / analysis*
Female
Humans
Infant, Newborn
Phenytoin / adverse effects
Pregnancy
Prospective Studies
Retrospective Studies
Risk
Grant Support
ID/Acronym/Agency:
ES04326/ES/NIEHS NIH HHS
Chemical
Reg. No./Substance:
0/Anticonvulsants; 0/Biological Markers; 57-41-0/Phenytoin; EC 3.3.2.-/Epoxide Hydrolases
Comments/Corrections
Comment In:
N Engl J Med. 1993 Nov 25;329(22):1660-1   [PMID:  8232451 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Platelet hyperreactivity and prognosis in survivors of myocardial infarction.
Next Document:  Abnormal sexual development in transgenic mice chronically expressing müllerian inhibiting substanc...